u/No_Major_2184

The Business: TelyRx offers access to more than 400 everyday medications across 48 U.S. states and territories. After a patient completes an online health assessment (no video required) and receives a prescription through a provider using the platform, TelyRx fulfills the prescription through its licensed retail pharmacies and ships medications directly to the patient.

The Hook: The U.S. allows for self-attestation of medical needs, so the prescriptions can be written by a third party doctor without the need for a video call.

Growth: 50%+ CQGR since inception at a 4.5x LTV/CAC per the RTO

For Q1 2026, TelyRx reported:

• Revenue: US$19.4 million
• Gross profit: US$10.7 million
• Gross margin: 55%
• Prescriptions filled: 236,000
• Adjusted EBITDA loss: US$2.3 million

 Current Metrics:

• Market Cap: C$136 million
• Cash: C$37 million
• Debt: C$14 million
• EV: C$113 million
• 2026F Rev / EV: 1.0x
• Canaccord: Buy C$6.00, trading at C$2.80

 I am long and looking to buy more!